Joint Statement from ACC, STS, and SCAI on the Transcatheter Aortic Valve Replacement National Coverage Determination
WASHINGTON—The American College of Cardiology (ACC), The Society of Thoracic Surgeons (STS), and the Society for Cardiovascular Angiography and Interventions (SCAI), released the following joint statement on the transcatheter aortic valve replacement (TAVR) national coverage determination released by the Centers for Medicare and Medicaid Services (CMS).
"The American College of Cardiology, Society of Thoracic Surgeons, and Society for Cardiovascular Angiography and Interventions, appreciate CMS's efforts to evolve Medicare coverage for TAVR and enhancing access to more patients as the evidence supporting this therapy continues to grow.
As TAVR expands into new patient populations, it is critical to preserve the quality framework that has contributed to its success. The preservation of the Heart Team, continued collaboration across specialties, collection of Real World Evidence outcomes, monitoring, and continuous quality improvement are the foundation of ensuring and improving outcomes for our patients with severe aortic stenosis.
Participation in national registries, externally benchmarked quality programs and rigorous outcomes reporting remain essential to preserving the high standards of care that have defined TAVR's success. The societies will continue to support the STS/ACC TVT Registry and other quality initiatives that promote evidence generation, patient safety, continuous improvement and health care value across the cardiovascular community."
SCAI has developed a detailed analysis of the new NCD and what it means for the interventional cardiology community: https://www.scai.org/media-center/news-and-articles/final-tavr-ncd-released-key-changes-and-next-steps
Find More:
Renal Denervation Topic Center
Cardiovascular Ambulatory Surgery Centers (ASCs) Topic Center
Grand Rounds With Morton Kern, MD
Peripheral Artery Disease Topic Center
